HIGHLIGHTS
- who: Richard Howley et al. from the Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Saint Joseph`s University, Philadelphia, PA, USA have published the research work: 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy, in the Journal: Bioengineering 2023, 10, 496. of 21/04/2023
- what: Since the first approval in 1999, five ALA-based drugs have been approved by the U.S. FDA.
SUMMARY
The finding that enhanced PpIX biosynthesis can be induced by exogenously applied ALA in tumor cells has led to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.